| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.09 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |